{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:17:39Z","timestamp":1786997859975,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.vaccine.2017.09.085","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T17:39:53Z","timestamp":1507829993000},"page":"6422-6428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Risk factors of ICU or high dependency requirements amongst hospitalized pediatric pertussis cases: A 10 year retrospective series, Singapore"],"prefix":"10.1016","volume":"35","author":[{"given":"Chia-Yin","family":"Chong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee-Fu","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie Woon-Hui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchalika","family":"Acharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Cheng","family":"Thoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.09.085_b0005","unstructured":"WHO Pertussis. <http:\/\/www.who.int\/ith\/diseases\/pertussis\/en\/>."},{"key":"10.1016\/j.vaccine.2017.09.085_b0010","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp1209051","article-title":"Epidemic pertussis in 2012 \u2013 the resurgence of a vaccine-preventable disease","volume":"367","author":"Cherry","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.09.085_b0015","unstructured":"Pertussis vaccines: WHO position paper-August 2015. Weekly Epidemiol Record 2015;35:433\u201360."},{"key":"10.1016\/j.vaccine.2017.09.085_b0020","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.09.085_b0025","first-page":"225","article-title":"The national childhood immunization programmes in Singapore","volume":"26","author":"Goh","year":"1985","journal-title":"Singapore Med J"},{"key":"10.1016\/j.vaccine.2017.09.085_b0030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jhin.2015.09.009","article-title":"Temporal trend in the incidence of pertussis and exposures among healthcare workers: descriptive report from a tertiary care hospital for children in Singapore","volume":"91","author":"Chong","year":"2015","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.vaccine.2017.09.085_b0035","doi-asserted-by":"crossref","first-page":"e010386","DOI":"10.1136\/bmjopen-2015-010386","article-title":"Epidemiology of pertussis related paediatric intensive care unit (ICU) admissions in Australia, 1997\u20132013: an observational study","volume":"6","author":"Kaczmarek","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2017.09.085_b0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/PCC.0000000000000851","article-title":"Burden and outcomes of severe pertussis infection in critically ill infants","volume":"17","author":"Straney","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.vaccine.2017.09.085_b0045","article-title":"Morbidity and mortality risk factors of pertussis in pediatrics","author":"Jordan","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2017.09.085_b0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/cid\/cir836","article-title":"The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent coccoon immunization","volume":"54","author":"Skowronski","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.085_b0055","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/JCM.40.5.1719-1722.2002","article-title":"Real-time lightCycler PCR for detection and discrimination of Bordetella pertussis and Bordetella parapertussis","volume":"40","author":"K\u00f6sters","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.09.085_b0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-0500-4-11","article-title":"A real-time PCR assay with improved specificity for detection and discrimination of all clinically relevant Bordetella species by the presence of distribution of three insertion sequence elements","volume":"4","author":"Roorda","year":"2011","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vaccine.2017.09.085_b0065","unstructured":"Chiarello P, Magnolia M, Rubina M, Liguori SA, Miniero R. Thrombocytosis in children. Minerva Pediatr 2011;63:507\u201313."},{"issue":"4","key":"10.1016\/j.vaccine.2017.09.085_b0070","doi-asserted-by":"crossref","DOI":"10.1097\/PCC.0b013e31828a70fe","article-title":"Critical pertussis illness in children, a multicenter prospective cohort study","volume":"14","author":"Berger","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.vaccine.2017.09.085_b0075","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/514792","article-title":"Epidemiological features of pertussis in hospitalized patients in Canada, 1991\u20131997: report of the immunization monitoring program\u2014active (IMPACT)","volume":"28","author":"Halperin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.085_b0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.inf.0000247055.81541.04","article-title":"The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada","volume":"26","author":"Bettinger","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.09.085_b0085","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jpeds.2012.05.041","article-title":"California pertussis epidemic, 2010","volume":"161","author":"Winter","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2017.09.085_b0090","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1067\/S0022-3476(03)00365-2","article-title":"Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada","volume":"143","author":"Mikelova","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2017.09.085_b0095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1542\/peds.97.5.607","article-title":"Pertussis deaths: report of 23 cases in the United States, 1992 and 1993","volume":"97","author":"Wortis","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.09.085_b0100","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/INF.0b013e31818c9032","article-title":"Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004","volume":"28","author":"Haberling","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.09.085_b0105","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/cid\/civ472","article-title":"Risk factors associated with infant deaths from pertussis: a case-control study","volume":"61","author":"Winter","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.085_b0110","doi-asserted-by":"crossref","unstructured":"Murray EL, Nieves D, Bradley JS, Gargas J, Mason WH, Lehman D, et al. Characteristics of severe Bordetella pertussis infection among infants \u2264 90 days of age admitted to pediatric intensive care units \u2013 Southern California. September 2009\u2013June 2011. J Pediatr Infect Dis Soc 2013;2:1\u20136.","DOI":"10.1093\/jpids\/pis105"},{"key":"10.1016\/j.vaccine.2017.09.085_b0115","unstructured":"Long SS. Pertussis (Bordetella pertussis and Bordetella parapertussis). In: Kliegman RM, Stanton BF, St. Geme JW, Schor NF, editors. Nelson textbook of pediatrics. 20th ed. Philadelphia, PA: Elsevier; 2016. p. 1377\u201382.e1 [chapter 197]."},{"key":"10.1016\/j.vaccine.2017.09.085_b0120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/589753","article-title":"Pathology and pathogenesis of fatal Bordetella pertussis infection in infants","volume":"47","author":"Paddock","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.085_b0125","doi-asserted-by":"crossref","unstructured":"Barlow RS, Reynolds LE, Cieslak PR, Sullivan AD. Vaccinated children and adolescents with pertussis infections experience reduced illness severity and duration, Oregon, 2010\u20132012. Clin Infect Dis 2014;58:1523\u20139 [Tiwari TS, Baughman AL, Clark TA].","DOI":"10.1093\/cid\/ciu156"},{"key":"10.1016\/j.vaccine.2017.09.085_b0130","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1542\/peds.2014-2291","article-title":"First pertussis vaccine dose and prevention of infant mortality","volume":"135","author":"Tiwari","year":"2015","journal-title":"Pediatr"},{"key":"10.1016\/j.vaccine.2017.09.085_b0135","unstructured":"Ministry of Health, Singapore, Communicable Diseases Surveillance in Singapore 2015, Singapore. <http:\/\/www.moh.gov.sg\/content\/moh_web\/home\/Publications\/Reports\/2013\/Communicable_Diseases_Surveillance_in_Singapore_2015.html>."},{"issue":"S4","key":"10.1016\/j.vaccine.2017.09.085_b0140","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1093\/cid\/ciw550","article-title":"Pertussis in young infants throughout the world","volume":"63","author":"Cherry","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.085_b0145","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1016\/j.vaccine.2016.10.081","article-title":"Impact of a maternal immunization program against pertussis in a developing country","volume":"34","author":"Vizzotti","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.085_b0150","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.09.085_b0155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/ciu821","article-title":"A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and wales, 2012\u20132013","volume":"60","author":"Dabrera","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.085_b0160","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1093\/cid\/ciw559","article-title":"Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction","volume":"63","author":"Amirthalingam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.085_b0165","unstructured":"CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged < 12 months\u2014Advisory Committee on Immunization Practices (ACIP); 2011. MMWR Morb Mortal Wkly Rep 2011;60:1424\u20136."},{"key":"10.1016\/j.vaccine.2017.09.085_b0170","doi-asserted-by":"crossref","first-page":"e009536","DOI":"10.1136\/bmjopen-2015-009536","article-title":"Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study","volume":"6","author":"Walls","year":"2016","journal-title":"BMJ Open"},{"issue":"59","key":"10.1016\/j.vaccine.2017.09.085_b0175","first-page":"e1","article-title":"Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women","volume":"207","author":"Zheteyeva","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.09.085_b0180","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.vaccine.2015.12.046","article-title":"Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007\u20132013","volume":"34","author":"Kharbanda","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.085_b0185","doi-asserted-by":"crossref","first-page":"g4219","DOI":"10.1136\/bmj.g4219","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"Donegan","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2017.09.085_b0190","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.2012.14939","article-title":"Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California 2010","volume":"308","author":"Misegades","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.09.085_b0195","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/bmj.296.6622.612","article-title":"Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study","volume":"296","author":"Jenkinson","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.vaccine.2017.09.085_b0200","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1016\/j.vaccine.2012.03.059","article-title":"Comparative seroepidemiology of pertussis, diptheria and poliovirus antibodies in Singapore: waning pertussis immunity in a highly immunized population and the need for adolescent booster doses","volume":"30","author":"Lai","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.085_b0205","first-page":"1129","article-title":"Centers for disease control and prevention (CDC)","volume":"63","author":"Winter","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.09.085_b0210","doi-asserted-by":"crossref","first-page":"780","DOI":"10.47102\/annals-acadmedsg.V35N11p780","article-title":"Seroepidemiology of pertussis in adult population of Singapore","volume":"35","author":"Wilder-Smith","year":"2006","journal-title":"Ann Acad Med Singapore"},{"issue":"suppl 4","key":"10.1016\/j.vaccine.2017.09.085_b0215","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/00006454-199704001-00003","article-title":"Epidemiology of pertussis","volume":"16","author":"Black","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.09.085_b0220","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.vaccine.2010.12.065","article-title":"Pertussis-an underdiagnosed disease with high morbidity in Singapore children","volume":"29","author":"Goh","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.085_b0225","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.inf.0000145263.37198.2b","volume":"23","author":"Bisgard","year":"2004","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T22:54:57Z","timestamp":1693090497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17313531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":45,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0264410X17313531"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors of ICU or high dependency requirements amongst hospitalized pediatric pertussis cases: A 10 year retrospective series, Singapore","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}